A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients’ survival in gastric cancer

被引：0
|
作者：
Weili Wang
Ping Liao
Yijing He
机构：
[1] Xiangya Hospital,Department of Clinical Pharmacology, Institute of Clinical Pharmacology
[2] Central South University,Department of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis
[3] Xiangya Hospital,undefined
来源：
Cancer Immunology, Immunotherapy | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1379 / 1381
页数：2
相关论文
共 50 条
  • [31] Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
    Festino, Lucia
    Botti, Gerardo
    Lorigan, Paul
    Masucci, Giuseppe V.
    Hipp, Jason D.
    Horak, Christine E.
    Melero, Ignacio
    Ascierto, Paolo A.
    DRUGS, 2016, 76 (09) : 925 - 945
  • [32] Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
    Lucia Festino
    Gerardo Botti
    Paul Lorigan
    Giuseppe V. Masucci
    Jason D. Hipp
    Christine E. Horak
    Ignacio Melero
    Paolo A. Ascierto
    Drugs, 2016, 76 : 925 - 945
  • [33] Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
    Shen, Xian
    Zhao, Bin
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
  • [34] PD-L1 and PD-L2 expression in colorectal cancer
    Zeynep, Ozgul
    Funda, Canaz
    Evrim, Yilmaz
    Deniz, Arik
    Bulent, Yildiz
    Fatih, Yasar. N.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2023, 66 (01) : 31 - 37
  • [35] Autophagy inhibition enhances PD-L1 expression in gastric cancer
    Wang, Xiaojuan
    Wu, William K. K.
    Gao, Jing
    Li, Zhongwu
    Dong, Bin
    Lin, Xiaoting
    Li, Yilin
    Li, Yanyan
    Gong, Jifang
    Qi, Changsong
    Peng, Zhi
    Yu, Jun
    Shen, Lin
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [36] PD-L1 as a Biomarker in Gastric Cancer Immunotherapy
    Cho, Yunjoo
    Ahn, Soomin
    Kim, Kyoung-Mee
    JOURNAL OF GASTRIC CANCER, 2025, 25 (01) : 177 - 191
  • [37] MLH1 expression is associated with PD-L1 expression, chemosensitivity and prognosis in gastric cancer
    Hashimoto, Tadayoshi
    Kurokawa, Yukinori
    Takahashi, Tsuyoshi
    Miyazaki, Yasuhiro
    Tanaka, Koji
    Makino, Tomoki
    Yamasaki, Makoto
    Nakajima, Kiyokazu
    Mori, Masaki
    Doki, Yuichiro
    CANCER SCIENCE, 2018, 109 : 427 - 427
  • [38] Optimized PD-L1 scoring of gastric cancer
    Birgid Schoemig-Markiefka
    Jana Eschbach
    Andreas H. Scheel
    Aylin Pamuk
    Josef Rueschoff
    Thomas Zander
    Reinhard Buettner
    Wolfgang Schroeder
    Christiane J. Bruns
    Heike Loeser
    Hakan Alakus
    Alexander Quaas
    Gastric Cancer, 2021, 24 : 1115 - 1122
  • [39] Profile of programmed death ligand-1 (PD-L1) expression and PD-L1 gene amplification in Indonesian colorectal cancer patients.
    Budiyati, Akterono Dwi
    Putra, Teguh Pribadi
    Kusumo, Gita Dewi
    Rexana, Fritzie
    Kurniawan, Antonius
    Sudoyo, Aru Wisaksono
    Utomo, Ahmad Rusdan
    Utama, Andi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [40] Autophagy inhibition enhances PD-L1 expression in gastric cancer
    Xiaojuan Wang
    William K. K. Wu
    Jing Gao
    Zhongwu Li
    Bin Dong
    Xiaoting Lin
    Yilin Li
    Yanyan Li
    Jifang Gong
    Changsong Qi
    Zhi Peng
    Jun Yu
    Lin Shen
    Journal of Experimental & Clinical Cancer Research, 38
12345